JPH0336510B2 - - Google Patents

Info

Publication number
JPH0336510B2
JPH0336510B2 JP60124554A JP12455485A JPH0336510B2 JP H0336510 B2 JPH0336510 B2 JP H0336510B2 JP 60124554 A JP60124554 A JP 60124554A JP 12455485 A JP12455485 A JP 12455485A JP H0336510 B2 JPH0336510 B2 JP H0336510B2
Authority
JP
Japan
Prior art keywords
biphenyl
gene
strain
pseudomonas aeruginosa
pmfb1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60124554A
Other languages
Japanese (ja)
Other versions
JPS61282069A (en
Inventor
Kensuke Furukawa
Toshitsugu Myazaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Institute of Advanced Industrial Science and Technology AIST
Original Assignee
Agency of Industrial Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency of Industrial Science and Technology filed Critical Agency of Industrial Science and Technology
Priority to JP60124554A priority Critical patent/JPS61282069A/en
Publication of JPS61282069A publication Critical patent/JPS61282069A/en
Publication of JPH0336510B2 publication Critical patent/JPH0336510B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

(イ) 本発明はビフエニル代謝機能を有する形質転
換微生物に関するものであつて、該微生物を用い
て化合物2−ハイドロキシン−6−オキソ−6
−フエニルヘキサ−2,4−ジエノイツクアシツ
ド及びその誘導体を製造せしめ病原菌として知ら
れている例えばスタフイロコツカス属などのグラ
ム陽性菌及び大腸菌などのグラム陰性菌に対する
殺菌剤や生理活性物質等の中間体として用途が期
待されるものである。 (ロ) 従来の技術 従来、ビフエニルを資化する細菌については自
然界より数種類分離され、その代謝様式も検討さ
れているが、形質転換微生物については全く知ら
れていない。 そこで、本発明者らはビフエニル代謝機構に関
連する遺伝子についてかねてより研究を進めた結
果、シユウドモナス・シユウドアルカリゲネス由
来のビフエニル代謝機能に関与する遺伝子をとり
出すことに成功し、この外来遺伝子bph A−C
をベクターに組みかえ増殖効率の優れた宿主微生
物にビフエニル代謝機能を持たせた形質転換微生
物、シユウドモナス・エルギノーサを創製するに
至つた。 (ハ) 発明の構成 外来遺伝子bph A−Cの給源としては、ビフ
エニル代謝に関与する遺伝子を体内に保有する微
生物で、本発明者が自然界より分離したシユウド
モナス・シユウドアルカリゲネスKF707
(Pseudomonas PseudoalcaligenesKF707)
(FERM P−8297)を例示できる。 なお、本菌株の菌学的性質は以下のとおりであ
る。 〔菌学的性質〕 グラム 陰性 桿 菌 0.7×1.5〜2.0μ 極鞭毛 1本 色素産生 なし オキシダーゼ 陽性 スターチ加水分解 陰性 41℃での生育 陽性 最適生育温度 35℃ 質化性グルコース、こはく酸、乳酸、ピルビン酸 以上の菌学的性質からバージイーズ マニユア
ル オブ システイ マテイクバクテリオロジ
ー、第9版に基づき検索した結果、シユウドモナ
ス・シユウドアルカリゲネス(Pseudomonas・
Pseudoalcaligenes)と認められた。 次に、本菌株からの該遺伝子の切出しは、前記
菌株を例えばL培地(バクトトリプトン10g、イ
ーストエキス5g、食塩5g、蒸溜水1)の一
晩増殖させリゾチーム−SDS法により溶菌し染色
体DNAを調製し次いで、染色体DNA(1μg)を
制限酵素Xhoで切断することにより、本遺伝子
を得ることができる。 本遺伝子の各種制限酵素による切断数は第1表
に示すとおりである。
(b) The present invention relates to a transformed microorganism having a biphenyl metabolic function, which is used to synthesize the compound 2-hydroxyxine-6-oxo-6.
- Phenylhexa-2,4-dienoic acid and its derivatives are produced and used as bactericidal agents and physiologically active substances against Gram-positive bacteria such as Staphylococcus spp. and Gram-negative bacteria such as Escherichia coli, which are known as pathogenic bacteria. It is expected to be used as an intermediate. (b) Conventional technology Several types of bacteria that assimilate biphenyl have been isolated from nature, and their metabolic patterns have been studied, but nothing is known about transformed microorganisms. Therefore, the present inventors have been conducting research on genes related to the biphenyl metabolic mechanism, and as a result, succeeded in extracting a gene involved in the biphenyl metabolic function derived from Pseudomonas pseudoalcaligenes, and this foreign gene bph A -C
This led to the creation of a transformed microorganism, Pseudomonas aeruginosa, in which a host microorganism with excellent growth efficiency was given the ability to metabolize biphenyl. (C) Structure of the Invention The source of the foreign genes bph A-C is Pseudomonas pseudoalcaligenes KF707, which is a microorganism that carries genes involved in biphenyl metabolism in its body, and which the present inventor isolated from nature.
(Pseudomonas Pseudoalcaligenes KF707)
(FERM P-8297) is an example. The mycological properties of this strain are as follows. [Mycological properties] Gram-negative bacillus 0.7 x 1.5-2.0 μ Polar flagellum 1 Pigment production None Oxidase Positive starch hydrolysis Negative Growth at 41℃ Positive Optimum growth temperature 35℃ Qualifying glucose, succinic acid, lactic acid, Pyruvic acid Based on the above mycological properties, we searched based on the 9th edition of Virgies Manual of Systemic Bacteriology, and found that Pseudomonas alcaligenes.
Pseudoalcaligenes). Next, the gene is excised from the present strain by growing the strain overnight, for example, in L medium (10 g of Bactotryptone, 5 g of yeast extract, 5 g of salt, 1 part of distilled water) and lysing the chromosomal DNA using the lysozyme-SDS method. The present gene can be obtained by preparing chromosomal DNA (1 μg) and then cleaving the chromosomal DNA (1 μg) with the restriction enzyme Xho. The number of cleavages of this gene by various restriction enzymes is shown in Table 1.

【表】 また、本遺伝子の断片の制限酵素地図は第1図
に示されるとおりである。 次に、本遺伝子のビフエニル代謝様式と遺伝子
群との関係は次に示すとおりである。 上記反応式において、A、B、Cは反応を司る
酵素を示し、Aはビフエニル オキシゲナーゼB
はジヒドロキシジオール デヒドロゲナーゼCは
フエニルカテコール オキシゲナーゼを各々示し
ている。 また、これらの酵素に対応する遺伝子として、
bphA、bphB、bphCが存在しこれらの遺伝子は
オペロンを形成している。またPはプロモーター
を示す。 本遺伝子の利用にあたつては、例えば、大腸菌
エシエリヒア・コリKF637(Escherichia coli
KF637)(FERM P−8296)由来のpKF330を常
法により該菌株より取り出した後、制限酵素Xho
で切断後T4リガーゼで結合させ組換えプラス
ミドpMFB1そ構築する(第3図)。 なお、pKF330は第2図に示すようにカナマイ
シン耐性とストレプトマイシン耐性を有する
12.6kbのプラスミドである。カナマイシン耐性遺
伝子部位にはXhoなどの挿入失活部位を有して
おり、またカナマイシンのプロモーターを利用で
きる。 次に宿主株としてシユウドモナス・エルギノー
サKF204(Pseudomonas aeruginosa KF204
(FERM P−8295)が利用される。形質転換方
法及び形質転換体の選択にあたつては、該菌株の
対数増殖期(5×108細胞/ml)まで培養し、集
菌、洗浄後、冷バツフアー(10mM MOPS−
10mM RbCl−100mM MgCl2、PH7.0)に懸
濁し、次いで遠心後、冷バツフアー(100mM
MOPS−10mM RbCl−100mM CaCl2、PH
6.5)に再懸濁し0℃、30分インキユベートする。
次に遠心後、菌株を1/10量の冷バツフアーに懸
濁する。この0.2mlコンピテントセルに組換えプ
ラスミド(0.5μg)に加え0℃にて1時間インキ
ユベート後42℃で2分間ヒートシヨツクする。3
mlのL培地を加え、30℃で3時間インキユベート
した後ストレプトマイシン(200μg/ml)を含
むL−寒天培地上で組換えプラスミドを保有する
形質転換体を一次スクリーニングする。ビフエニ
ル遺伝子を保有する目的とする形質転換体(組換
え微生物)は2,3−ジヒドロキシビフエニル溶
液(1mg/ml)を一次スクリーニングで生じたコ
ロニーに噴霧することにより黄変するコロニーを
選択する。ビフエニル代謝遺伝子を含むクローン
はビフエニル及びビフエニル関連化合物より黄色
物質を蓄積させ確認後、黄色物質を酸性下(PH1
〜2)で酢酸エチルで抽出後、トリメチルシリル
化してGC−MSによる分析を行いこれが化合物
(図4)及びその誘導体であることを確認す
る。 (ニ) 実施例 実施例 1 ビフエニル資化性菌シユウドモナス・シユウド
アルカリゲネスKF707株(FERM P−8297)を
L培地で一晩培養し、集菌、洗浄後、0.1Mトリ
ス(PH7.9)1mM EDTAバツフアーに懸濁し、
リゾチーム(最終濃度2μg/ml)を加え、室温
で5分間インキユベートし、次に10%SDSを50μ
/mlになるように加え溶菌した。次いでプロナ
ーゼ、RNase処理をしたのちフエノール抽出を
行い、エーテルでフエノールを除去した。このよ
うにして調製したDNAは10mMトリス、1mM
EDTAバツフアーに透析した。 一方、プラスミドpKF330を有するエシエリヒ
ア・コリKF637(FERM P−8296)をL培地で
一晩培養し、アルカリ−SDS法によりpKF330を
調製した。染色体DNA及びプラスミドpKF330
を制限酵素Xhoで切断後、T4−リガーゼで連
結した。次いで組換えプラスミドを宿主株である
シユウドモナス・エルギノーサKF204(FERM
P−8295)に導入した。すなわち、対数増殖期
(約4×108セル/ml)のKF204株を集菌し、等量
の冷バツフアー(10mM MOPS、10mM
RbCl、100mM MgCl2、PH7.0)で洗浄後、冷
バツフアー(100mM MOPS、10mM
RbCl、100mM CaCl2、PH6.5)に再懸濁し、0
℃にて30分間放置した。次に遠心後、1/10量の冷
バツフアーに再懸濁し、その0.2ml細胞懸濁液
と精製したpMFB1(0.5μg)と0℃、1時間イン
キユベートした。42℃で2分間、ヒートシヨツク
した後、3mlのL培地を加え30℃で3時間培養し
た。ビフエニル代謝遺伝子群(bph A−C)の
組込まれたpMFB1を保有する形質転換体はスト
レプトマイシン(200μg/ml)を含むL−寒天
培地で2,3−ヒドロキシビフエニル溶液(1
mg/ml)を噴霧して黄色となるコロニーとして選
択した。次いで形質転換体ストレプトマイシン
200μg/mlを含むL培地で一晩培養後、常法に
よりプラスミドを調製した。次いで調製したプラ
スミドpMFB1をXhoIで切断すると7.9kbのbph
A−C遺伝子が切り出された。本遺伝子は第1図
に示す制限酵素切断点を有していた。 実施例 2 実施例1により得られたpMFB1を保有するシ
ユウドモナス・エルギノーサKF257を炭素源とし
てこはく酸(1mg/ml)を含むBSM寒天培地に
塗布(摂種))しビフエニル粉末をペトリ皿のふ
たにおいてビニールテープでシールした。KF257
株の増殖とともにビフエニル蒸気をとり込んだ菌
体は、ビフエニルを化合物に変化せしめ、培地
は鮮やかに黄変した。 上記の反応はpMFB1を保有しない宿主株シユ
ウドモナス・エルギノーサKF204(FERM P−
8295)では全く認められなかつた。 なお、宿主株及びpMFB1を保有するKF257に
ついて グラム染色 陰性 鞭 毛 1 ピオシアニン 生成 螢光色素 生成 至適生育温度 37℃ オキシダーゼ + GC含量 67% でんぷん加水分解 − 以上の性質等によりKF257株はシユウドモナ
ス・エルギノーサであることを確認した。 (ホ) 発明の効果 ビフエニル代謝機能を有する外来遺伝子bph
A−Cを増殖効率の優れた微生物に組換え、形質
転換微生物を用いて、化合物2−ハイドロキシ
−6−オキソ−6−フエニルヘキサ−2,4−ジ
エノイツクアシツド及びその誘導体を安価に製造
することが可能となる。
[Table] The restriction enzyme map of the fragment of this gene is shown in FIG. Next, the relationship between the biphenyl metabolic mode of this gene and the gene group is as shown below. In the above reaction formula, A, B, and C represent enzymes that control the reaction, and A is biphenyl oxygenase B.
indicates dihydroxydiol dehydrogenase, and C indicates phenylcatechol oxygenase. In addition, genes corresponding to these enzymes include
There are bphA, bphB, and bphC, and these genes form an operon. Moreover, P represents a promoter. When using this gene, for example, Escherichia coli KF637 (Escherichia coli
KF637) (FERM P-8296)-derived pKF330 was extracted from the strain using a conventional method, and then treated with the restriction enzyme Xho.
After cleavage, the recombinant plasmid pMFB1 was constructed by ligating with T4 ligase (Fig. 3). Furthermore, pKF330 has kanamycin resistance and streptomycin resistance as shown in Figure 2.
It is a 12.6kb plasmid. The kanamycin resistance gene site has an insertion inactivation site such as Xho, and the kanamycin promoter can be used. Next, we used Pseudomonas aeruginosa KF204 as a host strain.
(FERM P-8295) is used. For the transformation method and selection of transformants, the strain was cultured to the logarithmic growth phase (5 x 10 8 cells/ml), harvested, washed, and then placed in a cold buffer (10mM MOPS-
10mM RbCl-100mM MgCl2 , PH7.0), then centrifuged, and then suspended in cold buffer (100mM
MOPS-10mM RbCl-100mM CaCl2 , PH
6.5) and incubate at 0°C for 30 minutes.
Next, after centrifugation, suspend the strain in 1/10 volume of cold buffer. The recombinant plasmid (0.5 μg) was added to the 0.2 ml competent cells, incubated at 0°C for 1 hour, and then heat-shocked at 42°C for 2 minutes. 3
After adding ml of L medium and incubating at 30° C. for 3 hours, transformants carrying the recombinant plasmid are primarily screened on L-agar medium containing streptomycin (200 μg/ml). The target transformant (recombinant microorganism) carrying the biphenyl gene is selected by spraying a 2,3-dihydroxybiphenyl solution (1 mg/ml) onto the colonies generated in the primary screening to select colonies that turn yellow. After confirming that clones containing biphenyl metabolic genes accumulate yellow substances from biphenyl and biphenyl-related compounds, the yellow substances were collected under acidic conditions (PH1
After extraction with ethyl acetate in ~2), trimethylsilylation and analysis by GC-MS confirm that this is the compound (Figure 4) and its derivatives. (d) Examples Example 1 The biphenyl-assimilating bacterium Pseudomonas pseudoalcaligenes KF707 strain (FERM P-8297) was cultured overnight in L medium, collected, washed, and then cultured in 0.1M Tris (PH7.9) 1mM. Suspended in EDTA buffer,
Add lysozyme (final concentration 2 μg/ml) and incubate for 5 min at room temperature, then add 50 μg of 10% SDS.
/ml and lysed. Next, the mixture was treated with pronase and RNase, followed by phenol extraction, and the phenol was removed with ether. The DNA thus prepared was prepared in 10mM Tris, 1mM
Dialyzed into EDTA buffer. On the other hand, Escherichia coli KF637 (FERM P-8296) containing plasmid pKF330 was cultured overnight in L medium, and pKF330 was prepared by the alkaline-SDS method. Chromosomal DNA and plasmid pKF330
was cleaved with restriction enzyme Xho and ligated with T4-ligase. The recombinant plasmid was then transferred to the host strain Pseudomonas aeruginosa KF204 (FERM
P-8295). That is, the KF204 strain in the logarithmic growth phase (approximately 4 × 10 8 cells/ml) was collected, and an equal volume of cold buffer (10mM MOPS, 10mM
After washing with RbCl, 100mM MgCl 2 , PH7.0), cool buffer (100mM MOPS, 10mM
Resuspend in RbCl, 100mM CaCl2 , PH6.5) and
It was left at ℃ for 30 minutes. After centrifugation, the cells were resuspended in 1/10 volume of cold buffer and incubated with 0.2 ml of the cell suspension and purified pMFB1 (0.5 μg) at 0° C. for 1 hour. After heat-shocking at 42°C for 2 minutes, 3 ml of L medium was added and cultured at 30°C for 3 hours. Transformants carrying pMFB1 containing the biphenyl metabolic gene cluster (bph A-C) were incubated with 2,3-hydroxybiphenyl solution (1
(mg/ml) was sprayed and the colonies that turned yellow were selected. Then the transformant streptomycin
After culturing overnight in L medium containing 200 μg/ml, a plasmid was prepared by a conventional method. Next, the prepared plasmid pMFB1 was cut with XhoI, resulting in a 7.9kb bph
The A-C gene was excised. This gene had the restriction enzyme cleavage point shown in FIG. Example 2 Pseudomonas aeruginosa KF257 carrying pMFB1 obtained in Example 1 was applied (inoculated) on a BSM agar medium containing succinic acid (1 mg/ml) as a carbon source, and biphenyl powder was placed on the lid of a Petri dish. I sealed it with vinyl tape. KF257
As the strain multiplied, the bacterial cells that took in biphenyl vapor converted biphenyl into a compound, and the medium turned bright yellow. The above reaction was performed using the host strain Pseudomonas aeruginosa KF204 (FERM P-
8295) was not recognized at all. In addition, the host strain and KF257 carrying pMFB1 were Gram-stained negative flagella 1 Pyocyanin Produced fluorescent pigment Optimum growth temperature for production 37℃ Oxidase + GC content 67% Starch hydrolysis - Due to the above properties, the KF257 strain is Pseudomonas aeruginosa. It was confirmed that (e) Effects of the invention Foreign gene bph having biphenyl metabolic function
A-C is recombined into a microorganism with excellent growth efficiency, and the transformed microorganism is used to inexpensively produce the compound 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid and its derivatives. becomes possible.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は外来遺伝子bph A−Cの制限酵素切
断地図を示す。第2図はエシエリヒヤ・コリ由来
のプラスミドpKF330の構造を示す。第3図は組
換えプラスミドpMFB1の作製手順とその構造を
示す。
FIG. 1 shows a restriction enzyme cleavage map of the foreign genes bph A-C. Figure 2 shows the structure of plasmid pKF330 derived from Escherichia coli. Figure 3 shows the procedure for producing recombinant plasmid pMFB1 and its structure.

Claims (1)

【特許請求の範囲】 1 シユウドモナス・シユウドアルカリゲネス由
来のビフエニル代謝機能を有する外来遺伝子であ
つて、分子量が7.9キロベースであり、次の制限
酵素において塩基の切断数が特徴づけられる外来
遺伝子 を、エシエリヒア・コリ由来のベクターpKF330
に組換え、組換えられたプラスミドpMFB1を宿
主微生物シユウドモナス・エルギノーサに形質転
換したビフエニル代謝機能を備えたことを特徴と
する形質転換微生物シユウドモナス・エルギノー
サKF257株。
[Scope of Claims] 1. A foreign gene derived from Pseudomonas pseudoalcaligenes and having a biphenyl metabolic function, which has a molecular weight of 7.9 kilobases and is characterized by the number of bases cleaved by the following restriction enzymes: Vector pKF330 from Escherichia coli
A transformed microorganism Pseudomonas aeruginosa strain KF257 is characterized in that it has a biphenyl metabolic function, which is obtained by transforming the recombined plasmid pMFB1 into a host microorganism Pseudomonas aeruginosa.
JP60124554A 1985-06-08 1985-06-08 Transformed basterium pseudomonas aeruginosa 257 strain having biphenyl metabolizing function Granted JPS61282069A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60124554A JPS61282069A (en) 1985-06-08 1985-06-08 Transformed basterium pseudomonas aeruginosa 257 strain having biphenyl metabolizing function

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60124554A JPS61282069A (en) 1985-06-08 1985-06-08 Transformed basterium pseudomonas aeruginosa 257 strain having biphenyl metabolizing function

Publications (2)

Publication Number Publication Date
JPS61282069A JPS61282069A (en) 1986-12-12
JPH0336510B2 true JPH0336510B2 (en) 1991-05-31

Family

ID=14888350

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60124554A Granted JPS61282069A (en) 1985-06-08 1985-06-08 Transformed basterium pseudomonas aeruginosa 257 strain having biphenyl metabolizing function

Country Status (1)

Country Link
JP (1) JPS61282069A (en)

Also Published As

Publication number Publication date
JPS61282069A (en) 1986-12-12

Similar Documents

Publication Publication Date Title
US5629190A (en) Polypeptides possessing a nitrilase activity and method of converting nitriles to carboxylates by means of said polypeptides
CN103497911B (en) Application of Chryseobacterium sp. and carbonyl reductase thereof in production of aprepitant chiral intermediate
JP4705089B2 (en) Process for producing (S)-or (R) -3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid
CN101679963A (en) Gene-disrupted strain, recombinant plasmid, transformant and method of producing 3-carboxymuconolactone
JP3154633B2 (en) Regulators for nitrilase gene expression and their genes
CN112852912A (en) Method for synthesizing 7-aminodesacetoxycephalosporanic acid
CN111454998A (en) A kind of biological preparation method of chiral hydroxy ester
WO2001042436A2 (en) Genes involved in cyclododecanone degradation pathway
JPH0740936B2 (en) Ascorbic acid intermediates and process enzymes
JPH0336510B2 (en)
US5308765A (en) Esterase genes, esterase, recombinant plasmids and transformants containing the recombinant plasmid and methods of producing optically acitve carboxylic acids and their enantiomeric esters using said transformants
JPH0342071B2 (en)
JPH0336515B2 (en)
Croes et al. Regulation of methanol oxidation and carbon dioxide fixation in Xanthobacter strain 25a grown in continuous culture
CN101137743B (en) Escherichia strain capable of converting XMP into GMP and keeping genes related to GMP degradation in an inactivated state and method of use thereof
US5306625A (en) Process for terminal hydroxylation of ethyl groups on aromatic 5- or 6-ring heterocycles
JPS63157986A (en) Production of l-phenylalanine by gene recombination
JPH0511960B2 (en)
FI129574B (en) Variants of bacterial strains and processes for the production of protein or biomass
JP2598718B2 (en) Novel indole-3-pyruvate decarboxylase and method for producing the same
CN115975965A (en) Lactate dehydrogenase and coding gene, recombinant vector, recombinant bacterium and leavening agent thereof, and application of lactate dehydrogenase and coding gene, recombinant vector, recombinant bacterium and leavening agent
CN116024110A (en) An engineering bacterium containing fatty acyl-CoA dehydrogenase and its application method
CN121343970A (en) A nitrile hydrolase mutant and its application
CN121826015A (en) Production-generation-time-controllable hirudin escherichia coli engineering bacteria, construction method and application thereof
JPH0761267B2 (en) Recombinant vector and bacterium having the same

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term